Sharechat Logo

Serko Limited (NZX: SKO) NZ$75 Million Placement Fully Subscribed

Thursday 25th November 2021

Text too small?

Serko Limited (NZX/ASX:SKO) ("Serko"), a leader in online travel booking and expense management for business, is pleased to announce the successful completion of its NZ$75 million placement (the "Placement"). The Placement was fully subscribed at the price determined in the bookbuild of NZ$7.05 per share. This represents a 10.2% discount to the closing price of NZ$7.85 on 23 November 2021.

The Placement was well supported, attracting bids well in excess of the NZ$75 million total offer amount from institutional and other select investors in both local and offshore markets.

Serko CEO Darrin Grafton said, “The capital raising enables Serko to continue to invest to capture the growth opportunities across key markets, and realise our vision of transforming from an online booking tool into a global marketplace. We are pleased with the level of support received for the raise from new and existing investors.”

Settlement of the Placement is expected to occur on 30 November 2021 for the ASX and 1 December 2021 for the NZX, with allotment and commencement of trading on NZX and ASX expected to occur on 1 December 2021. The new shares issued under the Placement will rank equally with Serko's existing ordinary shares.

Please see the link below for details

Placement Completion Announcement

Source: Serko Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Meridian Energy monthly operating report for July 2022
Cannasouth to launch a pro-rata renounceable rights issue
August 12th Morning Report
2022 Annual Shareholders' Meeting & Director Nominations
Rakon 2022 Annual Meeting Chair's Address and Presentation
VHP - Full year results release
RAKON FY23 Earnings Guidance
August 11th Morning Report
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query